1 hr ago | Rehab Management
JDRF through the Joint JDRF-Helmsley Charitable Trust Initiative...
Partnership Announced Between Leaders of Artificial Pancreas Research and Development to Develop Novel Redundant Sensor System to Help Improve Glucose Control for People with Diabetes -- /PRNewswire-USNewswire/ -- JDRF in collaboration with the Helmsley Charitable Trust announced today a partnership with Medtronic, Inc.
Experiment aims to tackle blood pressure
Now, in a high-stakes experiment at dozens of US hospitals, scientists are testing a dramatically different approach for the toughest way to treat patients, by burning away some overactive nerves deep in the body that can fuel rising blood pressure.
Supply Your Portfolio With Healthy Growth From Medical Suppliers
With baby boomers being one of the biggest population bubbles, medical suppliers can be a healthy addition to a portfolio.
Medtronic Hypertension Burning Seen as Industry Engine: Health
For three decades Gael Lander fought for her life against the same high blood pressure that contributed to her father's fatal heart attack and caused a series of debilitating strokes in her mother.
Medtronic Profit Beats Analyst Estimates on New Stent Demand
Medtronic Inc., the world's biggest maker of heart-rhythm devices, reported fourth-quarter profit that beat analyst estimates and said 2013 earnings will be as much as $3.70 a share.
Medtronic Earnings Up But Spinal Biz Drops
Wednesday, May. 23, 2012 Tuesday, May. 22, 2012 Monday, May. 21, 2012 Friday, May.
Medtronic Earnings: Rising Revenue Helps Margins Expand, Profit Rises
S&P 500 component Medtronic Inc. reported its results for the fourth quarter. Medtronic provides products and therapies for medical professionals.
Medtronic fourth quarter revenue increases 4% to $4.297 billion
Medtronic, Inc. today announced financial results for its fourth quarter and fiscal year ended April 27, 2012.
FDA's $6.4 Billion Plan for Quick Reviews Moves to Senate
Medtronic's capsure sense lead, a device that is inserted into a heart pacemaker.
A less-invasive way to replace heart valves
Analysts see a booming market for transcatheter heart valves. But most of the sales will be in Europe -- for now.
Photos: USA Road Mile Championships
Over 3,100 runners took to Nicollet Mall in Minneapolis for the 8th Annual Medtronic TC 1 Mile, running in 7 separate waves.
Miller and Kampf claim USA 1 Mile Road titles
Craig Miller and Heather Kampf took the respective men's and women's titles at the USA 1 Mile Road Championships Thursday evening in Minneapolis, Minnesota.
Medtronic announces new results from CoreValve ADVANCE Study
Medtronic, Inc. today announced new results from the Medtronic CoreValve ADVANCE Study, which found that women and men benefitted similarly from the Medtronic CoreValveA System.
Twin Cities Running: May 17 - 20, 2012
While the weekend is full of races in and around the Twin Cities, the big race is actually taking place tonight in downtown Minneapolis, the Medtronic TC 1 Mile .
Medtronic Fourth Quarter Earnings Sneak Peek
S&P 500 component Medtronic, Inc. will unveil its latest earnings on Tuesday, May 22, 2012.
Medtronic says bone graft investigation is over
MINNEAPOLIS — Medical device maker Medtronic Inc. said Wednesday that federal prosecutors have closed their investigation of the company's InFuse bone graft.
CORRECTING and REPLACING Medtronic IN.PACT Drug-Eluting Balloon...
CORRECTING and REPLACING Medtronic IN.PACT Drug-Eluting Balloon Studies Show Significant Benefit of Novel Medical Device in Treating Narrowed Arteries Adding to the growing body of evidence on a novel interventional cardiovascular device, physicians presented today at EuroPCR 2012 the results of two multicenter, randomized controlled trials, the ... (more)
Medtronic Announces 2012 Analyst Meeting and Webcast
The meeting will include remarks from the Medtronic management team highlighting the company's strategy for delivering improved growth and creating long-term shareholder value.
St. Jude's Riata lead performed poorly in study
St. Jude Medical Inc's Riata defibrillator lead, which was recalled late last year, performed "significantly worse" than a competing lead called Quattro, sold by competitor Medtronic Inc, in a large study, researchers said.
Medtronic's Valiant Captivia Stent Graft now available in seven countries
Medtronic, Inc. is expanding availability of the ValiantA Captivia A Thoracic Stent Graft System in several countries, including China, Japan and the United States.